PLoS ONE 11(12):e0168396 Disclosures PB has acted as a consultant for Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Sanofi, Novo Nordisk and Horizon Pharma
Semaglutide 2.4 mg (Wegovy) has demonstrated cardiovascular benefits in the SELECT trial, though this benefit should not be assumed for all medications in this class
Supplemental Material Supplemental material, sj-docx-1-tan-10.1177_17562864251378845 for The effect of GLP-1 agonist on idiopathic intracranial hypertension: a systematic review and meta-analysis by Jamal Ahmad, Ahmed Mohamed Hamdy, Bahaa Elfakharany, Muhammad M
Therefore, first-fill is the critical window
Liver Health : Doctors are now using Wegovy to treat MASH (liver inflammation and scarring) by reducing liver fat